I had bought them [AVXL shares] as insurance on SAVA just in case AVXL came up with a knockout punch on AD last year
That's pretty interesting to me because I initially bought AVXL due to its more diverse pipeline and multiple potential drug candidates and shortly bought SAVA as insurance on AVXL just in case AVXL failed in AD and SAVA came up with a knockout punch on AD. Now a couple of years later with independent validation of Simufilam's MOA, I am increasing hopeful that SAVA also has the AD goods. AD kills by two companies I am invested in would be out of this universe lucky.